Waters Corporation (N:WAT)

Business Focus: Advanced Medical Equipment & Technology

Sector:  Healthcare Industry:  Advanced Medical Equipment & Technology
See Regulatory Filings on SEC
Company Contact
Address: 34 MAPLE ST
MILFORD MA 01757-3604
Tel: 1-508-4823448
Website: https://www.waters.com/nextgen/us/en.html
IR: See website
Key People
Christopher J. O'Connell
Chairman of the Board, President, Chief Executive Officer
Sherry L. Buck
Chief Financial Officer, Senior Vice President
Keeley A Aleman
Senior Vice President, General Counsel and Corporate Secretary
Elizabeth B. Rae
Senior Vice President - Global Human Resources
Robert G. Carson
Senior Vice President - Corporate Development
Michael C. Harrington
Senior Vice President - Global Markets
Ian S. King
Senior Vice President - Global Products
Jonathan M. Pratt
Senior Vice President and President of TA Instruments
Business Overview
Waters Corporation is an analytical instrument manufacturer. The Company operates through two segments: Waters and TA. It designs, manufactures, sells and services high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and post-warranty service plans. It also designs, manufactures, sells and services thermal analysis, rheometry and calorimetry instruments through its TA product line. It is also a developer and supplier of software-based products that interface with the Company's instruments, as well as other suppliers' instruments. Its LC and LC-MS instruments are utilized in a range of industries to detect, identify, monitor and measure the chemical, physical and biological composition of materials, and to purify a range of compounds.
Financial Overview
For the three months ended 28 March 2020, Waters Corporation revenues decreased 10% to $464.9M. Net income before extraordinary items decreased 49% to $53.6M. Revenues reflect Waters Instrument Systems segment decrease of 23% to $142.8M, Ta Instrument Systems segment decrease of 7% to $34.1M, China segment decrease of 48% to $47.2M, United States segment decrease of 4% to $143.9M.
Employees: 7,500 as of Dec 31, 2019
Reporting Currency: U.S. Dollars
Enterprise value: $13,187M as of Mar 28, 2020
Annual revenue (TTM): $2,358M as of Mar 28, 2020
EBITDA (TTM): $766.60M as of Mar 28, 2020
Net annual income (TTM): $536.77M as of Mar 28, 2020
Free cash flow (TTM): $429.66M as of Mar 28, 2020
Net Debt Last Fiscal Year: $1,502M as of Mar 28, 2020
Shares outstanding: 61,908,682 as of Apr 24, 2020
Index Membership: S&P 500
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization